Parkinson's Disease Trial, By Invitation NCT00001215 Sponsor: National Human Genome Research Institute (NHGRI) Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, By Invitation

NCT00001215
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People of any age who have been diagnosed with a lysosomal storage disorder, or who carry the gene for one, may be considered for this trial.
  • Family members of someone already diagnosed with a lysosomal storage disorder may be considered for this trial.
  • Healthy adults aged 18 and over, recruited through the NIH healthy volunteer programme or as unaffected spouses or relatives of someone with the condition, may be considered for participation as a comparison group.
  • Adults aged 18 and over who have been diagnosed with Parkinson's disease may be considered for participation as a comparison group.
  • People with cognitive impairment may be considered if a legal guardian or authorised decision-maker provides consent on their behalf, and agreement from the participant is also sought where appropriate.
  • Pregnant or breastfeeding women may be considered, as no radiation or medical imaging is used in this trial for research purposes.
  • Adult family members of people with Gaucher disease — including parents, siblings, confirmed carriers, and relatives with or without Parkinson's disease — may be considered for this trial.
  • Family members who do not carry the relevant gene mutation and who volunteer to participate may be considered to serve as comparison participants.
  • People with Parkinson's disease who do not carry GBA1 gene mutations may be considered to serve as comparison participants.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who, in the opinion of the lead investigator, are unable to follow the study procedures, or who have medical or social circumstances that could increase the risk of taking part, may not be considered for this trial.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 August 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
National Human Genome Research Institute (NHGRI)
Registry
ClinicalTrials.gov
Start date
8 March 1995

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Clinical Phenotypes

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov